Peptide-based synthetic vaccines (epitope vaccines) are subunit vaccines made from peptides. The peptides mimic the epitopes of the antigen that triggers... 15 KB (1,726 words) - 04:31, 25 December 2023 |
peptide and launched a product called Curodont Repair in 2013. Recent studies show a positive clinical effect.[non-primary source needed] DNA vaccine... 12 KB (1,267 words) - 05:50, 14 April 2024 |
involving preventive vaccines. Cancer vaccines can be cell-based, protein- or peptide-based, or gene-based (DNA/RNA). Cell-based vaccines include tumor cells... 27 KB (3,112 words) - 22:49, 18 January 2024 |
EpiVacCorona (redirect from Vector COVID-19 vaccine) EpiVacCorona (Russian: ЭпиВакКорона, tr. EpiVacCorona) is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology... 39 KB (3,883 words) - 03:25, 12 February 2024 |
Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide... 65 KB (6,721 words) - 12:17, 22 March 2024 |
only the antigenic parts such as proteins, polysaccharides or peptides. Because the vaccine doesn't contain "live" components of the pathogen, there is... 67 KB (6,747 words) - 00:37, 12 April 2024 |
is the RVSV-ZEBOV vaccine licensed to Merck that is being used in 2018 to combat ebola in Congo. T-cell receptor peptide vaccines are under development... 139 KB (14,389 words) - 19:40, 15 April 2024 |
pathogen. The authorized vaccines of this type are the peptide vaccine EpiVacCorona, ZF2001, MVC-COV1901, Corbevax, the Sanofi–GSK vaccine, and Soberana 02 (a... 192 KB (21,930 words) - 19:29, 15 April 2024 |